Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Conference News TCT 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

Todd Neale

November 01, 2017

Presentation TCT 2017

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Presenter: Bernard R. Chevalier, Corrado Tamburino, Kai Xu

October 31, 2017

Presentation TCT 2017

Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Qi Zhang

October 31, 2017

Presentation TCT 2017

Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Luca Testa

October 31, 2017

Presentation TCT 2017

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 2: Inspiron

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Pedro A. Lemos

October 31, 2017

Presentation TCT 2017

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 1: Biomime

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Roberto Botelho

October 31, 2017

Presentation TCT 2017

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

Presenter: Ioannis Iakovou, Gert Richardt, Clemens von Birgelen

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Sunil V. Rao

October 30, 2017

Presentation ESC 2017

BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents

Presenter: David E Kandzari

September 13, 2017

News Industry News

STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions

July 28, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

News Industry News

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

May 16, 2017

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox

February 17, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

Advertisement

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update

Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 2: Inspiron

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 1: Biomime

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents

STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content